Results 61 to 70 of about 1,712 (210)

Comparison of Regular and As-needed Use of Mometasone Furoate Hydrate Nasal Spray for the Treatment of Japanese Cedar Pollinosis [PDF]

, 2019
application/pdfBackground: Intranasal glucocorticosteroids (INSs) are the first-line treatment for allergic rhinitis. However, it is not clear whether regular use of INSs during the pollen season is necessary for patients with Japanese cedar pollinosis ...
23880, 23881, 23882, 23883, 23884, 23885, MASUYAMA, Keisuke, MATSUOKA, Tomokazu, SAKAMOTO, Kaname, TAKAHASHI, Goro, TANAKA, Shota, YONAGA, Takaaki   +11 more
core   +1 more source

Oral Allergy Syndrome in Patients with Japanese Cedar Pollinosis.

Nippon Jibiinkoka Gakkai Kaiho, 2000
Patients with pollinosis sometimes complain of oral symptoms (itching and tingling with or without edema of the lips, mouth and tongue) after eating fresh fruits and vegetables. This condition has been termed Oral Allergy Syndrome (OAS). Twenty-three patients with Japanese cedar pollinosis and OAS for fresh fruits and vegetables were included in this ...
T, Ishida, K, Murai, T, Yasuda, T, Satou, T, Sejima, K, Kitamura   +5 more
openaire   +3 more sources

CRISPR/Cas9-mediated disruption of CjACOS5 confers no-pollen formation on sugi trees (Cryptomeria japonica D. Don)

Scientific Reports, 2023
Sugi (Cryptomeria japonica D. Don) is an economically important coniferous tree in Japan. However, abundant sugi pollen grains are dispersed and transported by the wind each spring and cause a severe pollen allergy syndrome (Japanese cedar pollinosis ...
Mitsuru Nishiguchi, Norihiro Futamura, Masaki Endo, Masafumi Mikami, Seiichi Toki, Shin-Ichiro Katahata, Yasunori Ohmiya, Ken-ichi Konagaya, Yoshihiko Nanasato, Toru Taniguchi, Tsuyoshi Emilio Maruyama   +10 more
doaj   +1 more source

New Allergens Approved by the WHO/IUIS Allergen Nomenclature Sub‐Committee in 2021–2024 and Their Significance for Future Diagnostics, Regulation, and Research. An EAACI Task Force Report

Allergy, Volume 81, Issue 3, Page 684-699, March 2026.
ABSTRACT The WHO/IUIS Allergen Nomenclature Sub‐Committee is an international body of experts that maintains the systematic nomenclature of allergenic proteins by assigning official names to newly identified allergens submitted by researchers. Here, we summarize the data on new allergens approved between 2021 and 2024.
Christian Radauer, Gabriele Gadermaier, Richard E. Goodman, Alain Jacquet, Uta Jappe, Andreas L. Lopata, Anna Pomés, Monika Raulf, Keity S. Santos, Josefina Zakzuk, Yuzhu Zhang, Joana Vitte, on behalf of the WHO/IUIS Allergen Nomenclature Sub‐Committee   +12 more
wiley   +1 more source

Allergies respiratoires, pollens et polluants [PDF]

, 2005
National audienceFor 30 years, an increased incidence of respiratory allergy and asthma has been observed, particularly in children and young people living in urban areas of developed countries.
Aberg, Beasley, Behrendt, Bousquet, Chitano, Davies, Diaz-Sanchez, Diaz-Sanchez, Diaz-Sanchez, Diaz-Sanchez, Diaz-Sanchez, Duchateau, Emberlin, Fujimaki, Fujimaki, G. Lacroix, Haahtela, Hartl, Helleday, Ishizaki, Kobayashi, Koenig, Kogevinas, Lacroix, Lacroix, Latvala, Lebowitz, Luczynska, Marks, Masuch, Masuch, Motta, Motta, Motta, Muranaka, Nabe, Nel, Ninan, Obtulowicz, Ohta, Omura, Pandya, Pauli, Peat, Peltre, Perdrizet, Pourazar, Riedel, Riedl, Ruffin, Rusznak, Sandström, Shaw, Steerenberg, Suphioglu, Takafuji, Thomsen, von Hertzen, von Mutius, Weiland, Wiedermann   +60 more
core   +2 more sources

Efficacy of Japanese cedar pollen sublingual immunotherapy tablets for Japanese cypress pollinosis

Journal of Allergy and Clinical Immunology: Global, 2023
We previously demonstrated the efficacy of Japanese cedar (JC) pollen sublingual immunotherapy (SLIT) tablets for treating seasonal allergic rhinitis in a clinical trial (trial no. 206-2-1) that covered 5 pollen dispersal seasons from 2015 to 2019.Our aim was to perform post hoc analysis of the 206-2-1 trial data to evaluate the efficacy of JC pollen ...
Tomoya Kurokawa, MD, PhD, Syuji Yonekura, MD, PhD, Minoru Gotoh, MD, PhD, Mitsuhiro Okano, MD, PhD, Yuriko Maekawa, BSc, Kimihiro Okubo, MD, PhD, Yoshitaka Okamoto, MD, PhD   +6 more
openaire   +3 more sources

Safety and efficacy of a new regimen of short-term oral immunotherapy with Cry j 1-galactomannan conjugate for Japanese cedar pollinosis: A prospective, randomized, open-label study

Allergology International, 2015
Background: Short-term oral immunotherapy (OIT) using the Cry j1-galactomannan conjugate for Japanese cedar pollinosis may be effective and relatively safe. However, a treatment regimen has not been established.
Daisuke Murakami, Motohiro Sawatsubashi, Sayaka Kikkawa, Masayoshi Ejima, Akira Saito, Akio Kato, Shizuo Komune   +6 more
doaj   +1 more source

Factors Affecting the Number of Pollen Grains per Male Strobilus in Japanese Cedar (Cryptomeria japonica)

Plants, 2021
Japanese cedar (Cryptomeria japonica) is the most important timber species in Japan; however, its pollen is the primary cause of pollinosis in Japan. The total number of pollen grains produced by a single tree is determined by the number of male strobili
Hiroyuki Kakui, Eriko Tsurisaki, Rei Shibata, Yoshinari Moriguchi   +3 more
doaj   +1 more source

LP‐003, a novel high‐affinity anti‐IgE antibody for inadequately controlled seasonal allergic rhinitis: A multicenter, randomized, double‐blind, placebo‐controlled phase 2 clinical trial

Clinical and Translational Allergy, Volume 15, Issue 6, June 2025.
Abstract Background Anti‐IgE therapy can serve as an option for inadequately controlled seasonal allergic rhinitis (SAR) patients. LP‐003, a novel anti‐IgE antibody, is being tested as an add‐on treatment for SAR. This trial aimed to evaluate whether LP‐003 is effective and safe for SAR.
Kai Guan, Shuang Liu, Yan Feng, Lisha Li, Xiaoming Zhu, Nai‐Chau‐Sun Bill, Haili Ma, Jie Yang, Cuicui Han, Heng Liu, Qingyu Wei, Haiyun Shi, Xueyan Wang   +12 more
wiley   +1 more source

A systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis [PDF]

, 2013
© Queen’s Printer and Controller of HMSO 2013Severe allergic rhinitis uncontrolled by conventional medication can substantially affect quality of life. Immunotherapy involves administering increasing doses of a specific allergen, with the aim of reducing
Barton, P, Dretzke, J, Fry-Smith, A, Huissoon, A, Kaambwa, B, Meadows, A, Meads, C, Novielli, N   +7 more
core   +1 more source